Half-year Financial Report

Summary by AI BETAClose X

Inspecs Group plc reported interim results for the six months ended 30 June 2026, with revenue increasing by 1.6% to £99.1m, driven by a 90 basis point increase in gross profit margin to 52.7% and a £1.5m decrease in operating expenses. Underlying EBITDA rose by 13.1% to £10.2m, with the margin improving to 10.3%, and diluted underlying EPS increased by 46% to 3.03p. The company strengthened its balance sheet with net debt excluding leases decreasing to £18.7m, and comfortably remained within its banking covenants. Strategic investment from Qualcomm of £7.4m was completed, and the wind-down of Norville progressed substantially. Despite challenging market conditions in some areas, the Group anticipates continued growth from Eschenbach eyewear and cost savings from operational efficiencies.

Disclaimer*

Inspecs Group PLC
10 September 2026
 

10 September 2026

INSPECS Group plc

("INSPECS", "the Company" or "the Group")

Interim Results

 

INSPECS Group plc, a leading designer, manufacturer and distributor of eyewear (sunglasses, optical frames and low vision products) presents its unaudited interim results for the six months ended 30 June 2026.

Financial review:

·      Revenue increased by 1.6% to £99.1m in H1 2026 from £97.6m in H1 2025

·      On a constant exchange rate basis1, revenue increased by 2.0% to £99.6m

·      Gross profit margin increased by 90 basis points to 52.7%, compared with 51.8% in H1 2025

·    Operating expenses decreased by £1.5m to £46.4m (H1 2025: £47.8m)

·    Underlying EBITDA2 increased by 13.1% to £10.2m from £9.0m in H1 2025, with the Underlying EBITDA margin increasing to 10.3% from 9.3%

·    Diluted Underlying EPS3 increased 46% to 3.03p from 2.08p in H1 2025

·    Operating profit before non-underlying items increased to £5.9m from £2.7m in H1 2025

·    Net working capital decreased by £3.5m during the period to £40.7m at 30 June 2026

·    Cash generated from operations remained strong at £10.8m, compared with £11.2m in H1 2025

·    Net debt excluding leases4 decreased by £13.6m to £18.7m at 30 June 2026 from £32.3m at 31 December 2025, including £7.4m net proceeds from the issue of new shares

·    The Group remained comfortably within its banking covenants at 30 June 2026, with leverage of 1.21x against a maximum covenant of 2.25x, debt service cover of 2.3x against a minimum of 1.1x and interest cover of 6.7x against a minimum of 3.0x.

Operational review:

·    Strategic investment of £7.4m by Qualcomm completed during the period, with the Group continuing to work closely with Qualcomm to progress strategic projects and identify opportunities to support future growth

·    The Group continued to implement operational efficiencies and cost-reduction initiatives across its businesses, including further integration within the European operations

·    The offer by Bidco 1125 Limited became unconditional on 12 March 2026

·    The wind-down of Norville progressed substantially during the period, with all remaining employees leaving the business and its inventory and property, plant and equipment sold

Current trading and outlook:

·    The Group entered the second half with a strengthened balance sheet, net debt excluding leases of £18.7m and good headroom against all banking covenants. While market conditions remain challenging, particularly within the US optical frames market and the German low vision market, the Group continues to benefit from growth within Eschenbach eyewear and the cost savings delivered through the integration of its UK operations.

·      We remain committed to delivering on our medium-term targets:

CAGR organic revenue growth 40% above the market rate, which is currently forecast to grow at 3% CAGR

Double-digit Underlying EBITDA margin - achieved in H1 2026

Net debt to be 40% - 75% of Underlying EBITDA - on track to deliver in 2027

 

1         Constant currency exchange rates: figures at constant currency exchange rates have been calculated using the average exchange rates in effect for the relevant comparative period (H1 2025).

2         Refer to table 'Underlying EBITDA and Underlying PAT'.

3         Refer to note 5.

4         Refer to note 9.

 

Richard Peck, CEO of INSPECS, said:

"The Group delivered revenue growth in the first half of 2026, together with an improvement in gross margin and a 13.1% increase in Underlying EBITDA to £10.2m. This performance was achieved despite continued challenging conditions in a number of our markets and reflects the benefit of disciplined cost management, improved manufacturing performance and the operational efficiencies delivered across the Group.

 

"The Qualcomm investment during the period, combined with strong cash generation and continued focus on working capital and cost control, put the Group in a strong position heading into the second half of 2026. We remain focused on further operational efficiencies, cost discipline and the development of new business opportunities as we progress through the remainder of the year."

 

For further information please contact:

INSPECS Group plc

Richard Peck (CEO)

 

Tel: +44 (0) 1225 717 000

Peel Hunt (Nominated Adviser and Broker)

George Sellar

Andrew Clark

 

 

Tel: +44 (0) 20 7418 8900

About INSPECS Group plc

INSPECS is a leading provider of eyewear solutions to the global eyewear market. The Group produces a broad range of eyewear frames and low vision aids, covering optical, sunglasses and safety, which are either "Branded" (under licence or under the Group's own proprietary brands), or "OEM" (unbranded or private label on behalf of retail customers).

INSPECS is building a global eyewear business through its vertically integrated business model. Its continued growth is underpinned by increasing the penetration of its own-brand portfolio, worldwide distribution, growing retail presence, maximising group synergies and its global network, expanding its manufacturing capacity and scaling the research and development department as it develops new and innovative eyewear products.

The Group has operations across the globe: with offices and subsidiaries in the UK, Europe, the US and China (including Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China and Italy.

INSPECS customers are global optical and non-optical retailers, global distributors and independent opticians. Its distribution network covers over 80 countries and reaches approximately 75,000 points of sale.

More information is available at: www.INSPECS.com

CHIEF EXECUTIVE REVIEW

The Group delivered improved revenue and Underlying EBITDA during the first half of 2026 despite continued challenging market conditions, including subdued demand in certain European and US markets and ongoing uncertainty surrounding US tariffs.

Revenue increased by 1.6% to £99.1m in H1 2026 from £97.6m in H1 2025. On a constant exchange rate basis, revenue increased by 2.0% to £99.6m. Underlying EBITDA increased by 13.1% to £10.2m from £9.0m, with the Underlying EBITDA margin improving to 10.3% from 9.3%.

We remain focused on delivering sustainable revenue growth, improving operational performance and maintaining appropriate leverage. Our priorities include strengthening performance in our core markets, developing new customer and product opportunities, maintaining disciplined cost control and completing the remaining rationalisation and integration initiatives across the Group.

Frames and Optics

Revenue from the Frames and Optics segment remained broadly consistent with the prior period at £91.3m. Underlying EBITDA was £10.4m compared with £10.5m in H1 2025.

Our European eyewear operations delivered continued growth, particularly through key accounts, although this was partly offset by weaker performance in the European low vision and optics market. Overall market conditions in Germany remained subdued, with continued volume pressure in core markets. Despite this backdrop, the German eyewear business delivered a strong performance, supported by the successful execution of strategic initiatives, the benefits of recent leadership changes and the continued strength of key proprietary brands. The European operations maintained a strong focus on product development, design, quality and service, alongside disciplined cost management.

The US optical frames market remained challenging during the period, with industry-wide volume pressure affecting demand across a number of channels. Key-account activity was stronger in certain areas, while opportunities within safety eyewear and sunglasses continued to progress.

 

Manufacturing

Revenue from the Manufacturing segment increased by 33.3% to £10.5m in H1 2026 from £7.9m in H1 2025. Underlying EBITDA increased to £1.2m from £0.4m, reflecting higher revenue and improved factory performance, partly offset by a modest reduction in gross margin and additional investment in manufacturing personnel.

Our Asian manufacturing operations delivered strong revenue growth compared with H1 2025, supported in part by delayed orders from 2025 being shipped during January and February 2026. Customer demand and order flow improved in certain areas, although gross margins continued to be affected by product mix and lower volumes of internally manufactured concepts, titanium and regular metal products.

Our manufacturing facility in Vietnam continued to operate effectively and increase production activity during the period. Management remains focused on increasing utilisation, broadening the customer base and securing further orders to support future revenue and margin growth.

Operational efficiencies

The Group continued to implement operational efficiencies and cost-reduction initiatives across its businesses including further integration within the European and UK operations. The wind-down of Norville also progressed substantially during the period. All remaining employees left the business and the sale of its inventory and property, plant and equipment was completed. The residual activities principally comprise the collection and settlement of outstanding balances and completion of the wind-down process.

 

 

ESG

During the period, the Group continued to progress initiatives intended to reduce emissions and improve energy efficiency across its global operations. These included continued investment in renewable energy and energy resilience within the Group's Asian manufacturing operations.

The Group has also continued its work on sustainable packaging and the measurement and management of Scope 3 emissions. We remain committed to delivering measurable progress against our ESG objectives and supporting our people, communities and the environment.

Corporate update

The offer by Bidco 1125 Limited became unconditional on 12 March 2026. The Group incurred £2.2m of professional fees and other transaction-related costs in connection with the proposed acquisition and subsequent offer during H1 2026.

During June 2026, the Group received net proceeds of £7.4m from the issue of new shares to Qualcomm. A portion of the proceeds was used to reduce drawings under the Group's revolving credit facility, strengthening liquidity and increasing available borrowing capacity. The Group continues to work closely with Qualcomm to progress strategic projects and identify opportunities to support future growth.

Outlook

Despite ongoing macroeconomic headwinds, the optical market remains resilient. Management remains focused on progressing new customer and product opportunities, as well as improving working capital, delivering further operational efficiencies and maintaining disciplined cost control.

I would like to take this opportunity to thank all our teams worldwide for their continued efforts and commitment to developing the Group as a leading global eyewear business.

 

Richard Peck

10 September 2026

 

 


 

 

FINANCIAL REVIEW

 

Revenue

Revenue was £99.1m for H1 2026, up from £97.6m in H1 2025, an increase of 1.6%. On a constant exchange rate basis, revenue increased 2.0% to £99.6m.

 

Gross Profit Margin

The Group's gross profit margin increased to 52.7% in H1 2026 versus 51.8% in H1 2025.

 

Operating Profit

The Group's operating profit before non-underlying items increased to £5.9m (H1 2025: £2.7m).

 

Administrative expenses

Administrative costs decreased by £1.5m to £43.7m in H1 2026 from £45.2m in H1 2025, a result of the Group's continuing focus on operational efficiency and cost discipline, together with lower amortisation charges as certain purchase price allocation intangible assets became fully amortised.

 

Underlying EBITDA

The Group's Underlying EBITDA increased to £10.2m in H1 2026 from £9.0m in H1 2025. Underlying EBITDA margin increased to 10.3% in H1 2026 from 9.3% in H1 2025.

 

Non-underlying costs

Non-underlying costs in H1 2026 of £2.5m predominantly relate to one-off transaction and advisory costs associated with the proposed acquisition and subsequent offer by Bidco 1125 Limited, which became unconditional on 12 March 2026.

 

Depreciation and amortisation


Period ended 30 June 2026 £m

Period ended 30 June 2025

£m

Depreciation

2.8

2.8

Amortisation

1.7

3.3

Total

4.5

6.1

 

The decline in amortisation is due to certain purchase price allocation intangible assets associated with the Eschenbach acquisition becoming fully amortised as of December 2025.

 

Profit Before Tax

Profit before tax for the period was £1.8m (H1 2025: £2.4m), including £2.5m of non-underlying costs incurred during H1 2026 (H1 2025: £0.2m) and after a nil gain on exchange adjustments on borrowings in H1 2026, compared to a gain of £1.4m in H1 2025.

 

Tax charge

The tax charge for the period of £1.9m (H1 2025: £2.1m) comprises a current tax charge of £2.7m (H1 2025: £2.6m) and a deferred tax credit of £0.8m (H1 2025: £0.5m credit). The deferred tax credit is as a result of the unwinding of deferred tax balances arising on acquisitions.

 

Cash Generation

The Group continued to have strong cash generation from operations of £10.8m (H1 2025: £11.2m).

 

Net Debt

Net debt excluding leases decreased by £13.6m to £18.7m at 30 June 2026 from £32.3m at 31 December 2025, reflecting strong  cash generation from trading and £7.4m net proceeds from the issue of new shares.

 

Financing

The Group finances its operations through the following borrowings and facilities.



Expires

Balance at
30 June 2026
£m

Balance at
31 December 2025
£m

Group revolving credit facility


December 2027

28.4

31.4

Term loans


December 2027

6.1

8.5

Revolving credit facility USA


1-year rolling

6.9

6.8

Invoice discounting


1-year rolling

3.2

1.6

Total



44.6

48.3

 

Leverage covenant

The Group's leverage position is shown below:


30 June

2026

31 December

2025

Actual ratio

1.21

2.22

Covenant ratio

2.25

2.25

The Group remains within its banking covenants and forecasts that it will continue to remain within banking covenants for the length of the arrangement.

 

Inventory

The revenue-to-inventory ratio declined marginally compared with 30 June 2025, when inventory levels were temporarily lower following reduced purchasing by the Group's US operations between April and June 2025 in response to tariff uncertainty.


Period ended 30 June 2026

£m

Period ended 30 June 2025

£m

Revenue

99.1

97.6

Inventory

 

46.1

42.0

Revenue to inventory ratio

2.1

2.3

 

Current asset ratio

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations, or those due within one year.


As at 30 June 2026

£m

As at 30 June

2025

£m

Current Assets

106.1

98.0

Current Liabilities

 

76.1

76.1

Ratio

1.4

1.3

 

Quick ratio

The quick ratio is an indicator of a company's short-term liquidity position and measures a company's ability to meet its short-term obligations with its most liquid assets.


As at 30 June 2026

£m

As at 30 June

2025

£m

Current Assets

106.1

98.0

Less Inventory

(46.1)

(42.0)


60.0

56.0

Current Liabilities

 

76.1

76.1

Ratio

0.8

0.7

 

Net working capital


As at 30 June 2026

£m

As at 30 June 2025

£m

As at 31 December 2025

£m

Trade and other receivables

33.4

33.2

37.5

Inventory

46.1

42.0

47.2

Trade and other payables

(38.8)

(36.9)

(40.5)

Net working capital

40.7

38.3

44.2

Working capital as a percentage of 12-month rolling revenue

21.1%

20.1%

23.1%

 

Earnings per Share

The Group's Diluted Underlying EPS for the 6 months to 30 June 2026 was 3.03p compared to 2.08p for the 6 months to 30 June 2025. The Group's Diluted EPS was a loss of 0.48p for the 6 months to 30 June 2026 (H1 2025: loss 4.54p).

 

Dividend

The Group does not currently intend to pay a dividend in relation to the first half of 2026. The Board continues to review its dividend policy on a regular basis.



 

Underlying EBITDA and Underlying PAT

 

The below table shows how Underlying EBITDA and Underlying PAT are calculated:

 



 

6 months ended 30 June 2026

 

6 months ended 30 June 2025

 

12 months ended 31 December 2025

 

 

 

£'000

 

£'000

 

£'000

 

Revenue


99,149


97,623


191,701


Gross Profit


52,275


50,570


99,176


Operating expenses


(46,374)


(47,834)


(93,491)

 

Operating profit before non-underlying items

 


 

5,901

 

 

2,736

 

5,685


Add back: Amortisation


1,710


3,270


6,197


Add back: Depreciation


2,762


2,758


5,608

 

EBITDA


10,373

 

8,764

 

17,490


(Deduct)/add back: Share-based payment credit/expense


 

(151)


 

277


185


Underlying EBITDA


10,222

 

9,041

 

17,675


Less: Depreciation


(2,762)


(2,758)


(5,608)


Less: Net interest (excluding amortisation of loan arrangement fees)


 

(1,519)


 

(1,433)


(2,789)


Underlying Profit Before Tax (PBT)


5,941

 

4,850

 

9,278


Current tax charge


(2,677)

 

(2,627)

 

(1,878)


Underlying Profit After Tax (PAT)


3,264

 

2,223

 

7,400


 


 

 

 

 

 

 


Underlying EPS


Pence

 

Pence

 

Pence


Basic Underlying EPS for the period attributable to the equity holders of the parent


 

3.19

 

 

 

2.19

 

 

7.28

 


 

Diluted Underlying EPS for the period attributable to the equity holders of the parent


 

 

3.03

 

 

 

2.08


 

 

6.87

 



 

Underlying EBITDA segmental information

Underlying EBITDA by reportable segment for the six months ended 30 June 2026 is as follows:


Frames &


Manufacturing


Total before


Adjustments


   Total


Optics




adjustments &


& eliminations








eliminations






 


      £'000


              £'000


£'000


£'000


 £'000

Revenue

91,305


10,478


101,783


(2,634)


99,149











Operating profit/(loss)

6,767


466


7,233


(1,332)


5,901

Add back:










Amortisation

1,397


313


1,710


-


1,710

Depreciation

2,314


417


2,731


31


2,762

Share-based payments

(75)


(23)


(98)


(53)


(151)

Underlying EBITDA

10,403

 

1,173

 

11,576

 

(1,354)

 

10,222

 

 

Underlying EBITDA by reportable segment for the six months ended 30 June 2025 is as follows:


Frames &


Manufacturing


Total before


Adjustments


   Total


Optics




adjustments &


& eliminations








eliminations






 


      £'000


              £'000


£'000


£'000


 £'000

Revenue

91,398


7,869


99,267


(1,644)


97,623











Operating profit/(loss)

5,117


(410)


4,707


(1,971)


2,736

Add back:










Amortisation

2,957


313


3,270


-


3,270

Depreciation

2,297


413


2,710


48


2,758

Share-based payments

96


57


153


124


277

Underlying EBITDA

10,467

 

373

 

10,840

 

(1,799)

 

9,041

 



 

INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME              


For the period ended 30 June 2026


Notes

Unaudited
6 months ended
30 June 2026

 

 

 

Unaudited
6 months ended
30 June 2025

 

 

 


            £'000

      

 

            £'000

      

REVENUE

4

99,149


97,623

Cost of sales


(46,874)


(47,053)

GROSS PROFIT

 

52,275


50,570

 

 




Distribution costs


(2,712)


(2,656)

Administrative expenses


(43,662)


(45,178)






OPERATING PROFIT BEFORE NON-UNDERLYING ITEMS

 

5,901


2,736






Non-underlying costs

10

(2,471)


(247)

Exchange adjustments on borrowings


(43)


1,399

Share of profit of associates


-


6

Finance costs


(1,668)


(1,612)

Finance income


37


72






PROFIT BEFORE INCOME TAX

 

1,756


2,354

Income tax


(1,885)


(2,087)






(LOSS)/PROFIT FOR THE PERIOD - CONTINUING OPERATIONS

 

(129)


267

 

LOSS FOR THE PERIOD - DISCONTINUED OPERATION

12

(359)


(4,879)

 

 




 

LOSS FOR THE PERIOD

 

(488)


(4,612)

 

OTHER COMPREHENSIVE PROFIT/(LOSS):

 




Exchange adjustment on consolidation


974


(6,560)






TOTAL COMPREHENSIVE PROFIT/(LOSS) FOR THE PERIOD

 

486


(11,172)








 

 

INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (continued)                                                                                                                              

For the period ended 30 June 2026


Notes

Unaudited
6 months ended
30 June 2026

 

 

 

Unaudited
6 months ended
30 June 2025

     

 

 

(Loss)/profit per share from continuing operations

 

 

Pence                    

 

 

Pence                    

Basic EPS for the period attributable

  to the equity holders of the parent

5

(0.13)


0.26

Diluted EPS for the period attributable

  to the equity holders of the parent

5

(0.13)


0.25

 

Loss per share

 

 

 

 

 

                    

Basic EPS for the period attributable

  to the equity holders of the parent

5

(0.48)


(4.54)

Diluted EPS for the period attributable

  to the equity holders of the parent

5

(0.48)


(4.54)









 

 

 

 

 



INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION    

As at 30 June 2026


 



Notes


Unaudited

As at
30 June 2026

£'000


Unaudited

As at
30 June 2025 (restated)

£'000

 

As at
31 December 2025

£'000

 

ASSETS









 

NON-CURRENT ASSETS









 

Goodwill




56,987


55,772


56,832

 

Intangible assets




15,431


20,504


16,848

 

Property, plant and equipment




22,950


25,310


24,253

 

Investment in associate and joint venture




54


70


54

 

Deferred tax




1,935


3,574


1,736

 





97,357


105,230


99,723

 

CURRENT ASSETS









 

Inventories




46,124


41,968


47,225

 

Trade and other receivables


6


33,448


33,167


37,465

 

Tax receivable




518


184


887

 

Cash and cash equivalents


7


25,961


22,667


15,986

 





106,051


97,986


101,563

 

Assets held for sale


12


-


2,392


944

 

TOTAL ASSETS

 

 

 

203,408

 

205,608

 

202,230

 










 

EQUITY









 

SHAREHOLDERS' EQUITY









 

Called up share capital




1,092


1,017


1,017

 

Share premium




96,871


89,508


89,508

 

Foreign currency translation reserve




20


(3,555)


(954)

 

Share option reserve




3,329


3,847


3,755

 

Merger reserve




5,340


5,340


5,340

 

Accumulated losses




(19,163)


(14,004)


(18,950)

 

TOTAL EQUITY




87,489


82,153


79,716

 

 









 

LIABILITIES









NON-CURRENT LIABILITIES









 

Financial liabilities - borrowings









 

      Interest bearing loans and borrowings




38,973


43,902


44,414

 

Deferred tax




803


1,673


1,425

 





39,776


45,575


45,839

 

CURRENT LIABILITIES









 

Trade and other payables


8


38,782


36,923


40,522

 

Right of return liability




15,622


16,027


15,655

 

Warranty provision




2,569


3,222


2,868

 

Financial liabilities - borrowings









 

      Interest bearing loans and borrowings




12,719


12,725


13,782

 

 Invoice discounting




3,185


2,012


1,580

 

Deferred and contingent consideration




-


991


-

 

Tax payable




3,266


4,237


2,268

 





76,143


76,137


76,675

 

Liabilities held for sale


12


-


1,743


-

 

TOTAL LIABILITIES




115,919


123,455


122,514

 

TOTAL EQUITY AND LIABILITIES

 

  

 

203,408

 

205,608

 

202,230

 

































INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the period ended 30 June 2026


 


       Called up share capital

Share premium

Foreign currency translation reserve

Share option reserve

Accumulated losses

Merger reserve

Total equity


£'000

£'000

£'000

£'000

£'000

£'000

£'000

 








SIX MONTHS ENDED 30 JUNE 2026








Balance at 1 January 2026

1,017

89,508

(954)

3,755

(18,950)

5,340

79,716

 








Loss for the period

-

-

-

-

(488)

-

(488)

Other comprehensive profit

-

-

974

-

-

-

974

Total comprehensive profit/(loss)

-

-

974

-

(488)

-

486

 

 

 

 

 

 

 

 

Issue of new shares

75

7,363

-

-

-

-

7,438

Transfer on lapse of vested share

options1

-

-

-

(275)

275

-

-

Reversal of share-based payment

charge1

-

-

-

(151)

-

-

(151)

Balance at

30 June 2026

(unaudited)

1,092

96,871

20

3,329

(19,163)

5,340

87,489

















SIX MONTHS ENDED 30 JUNE 2025

 

 

 

 

 

 

 

 

Balance at

1 January 2025

(restated)

1,017

89,508

3,005

3,570

(9,392)

5,340

93,048

 

 

 

 

 

 

 

 

 

 

Loss for the period

-

-

-

-

(4,612)

-

(4,612)

 

Other comprehensive loss

-

-

(6,560)

-

-

-

(6,560)

 

Total comprehensive loss

-

-

(6,560)

-

(4,612)

-

(11,172)

 

 

 

 

 

 

 

 

 

 

Share-based

payment charge

-

-

-

277

-

-

277

 

Balance at

30 June 2025

(unaudited) (restated)

1,017

89,508

(3,555)

3,847

(14,004)

5,340

82,153

 

 

 

 

 

 

 

 

 

 











1.        The current period movements comprise the reversal of cumulative charges relating to awards that did not vest and a transfer to retained earnings in respect of vested options that subsequently lapsed. The comparative balance at 30 June 2025 reflected awards that remained outstanding at that date.

INTERIM CONSOLIDATED STATEMENT OF CASH FLOW                            

For the period ended 30 June 2026

 


 

Notes

 

Unaudited

6 months ended

30 June 2026

 

 

Unaudited

6 months ended

30 June 2025      



£'000

 

£'000

Cash flows from operating activities





Profit before income tax


1,756


2,354

Adjustments for:





  Depreciation charges


2,762


2,758

  Amortisation charges


1,710


3,270

  Share-based payment (credit)/expense


(151)


277

  Exchange adjustments on borrowings


43


(1,399)

  Share of (profit)/loss from associate


-


(6)

  Finance costs


1,668


1,612

  Finance income


(37)


(72)



7,751

 

8,794

Decrease in inventories1


1,183


529

Decrease in trade and other receivables1


4,046


4,332

Decrease in trade and other payables1


(2,174)


(2,424)

Cash generated from operations


10,806

 

11,231

Interest paid


(1,876)


(1,576)

Tax paid


(1,341)


(1,852)

Cash outflows from discontinued operations


(359)


(1,586)

Net cash flow from operating activities


7,230

 

6,217






Cash flows used in investing activities

 

 

 

 

Purchase of intangible fixed assets


(257)


(504)

Purchase of property, plant and equipment


(664)


(563)

Cash paid in relation to deferred consideration


-


(700)

Interest received


37


72

Cash inflows from discontinued operations


907


265

Net cash flows from/(used in) investing activities


23

 

(1,430)






Cash flow from financing activities





Proceeds from issue of share capital, net of transaction costs


7,438


-

Bank loan principal repayments in period


(4,561)


(1,474)

Movement in invoice discounting facility


1,605


235

Loan transaction costs


-


(568)

Principal payments on leases


(1,917)


(1,755)






Net increase in cash and cash equivalents


9,818

 

1,225

Cash and cash equivalents at beginning of the period


15,986

 

23,960

Net foreign currency movements


157


(2,361)

Cash and cash equivalents at end of period

7

25,961

 

22,824







 

1.        The movement in working capital excludes the classification of the discontinued operations working capital as held for sale.

 

 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS

For the period ended 30 June 2026

 

1.      GENERAL INFORMATION

INSPECS Group plc is a public company limited by shares and is incorporated in England and Wales. The address of the Company's principal place of business is Kelso Place, Upper Bristol Road, Bath BA1 3AU.

The principal activity of the Group in the period was that of design, production, sale, marketing and distribution of high-fashion eyewear and OEM products worldwide.

2.      ACCOUNTING POLICIES

Going concern

Based on the Group's forecasts, the interim financial statements have been prepared on the going concern basis as the Directors have assessed that there is a reasonable expectation that the Group will be able to continue in operation and meet its commitments as they fall due over the going concern period to 30 September 2027.

The assessment has considered the Group's current financial position as follows:

•      The Group further improved its cash position during the period with net debt including leases decreasing to £28.9m at 30 June 2026 from £43.8m at 31 December 2025.

•      Cash generated from operations in the period amounted to £10.8m (H1 2025: £11.2m).

•      The Group balance sheet has net assets of £87.5m and net current assets of £29.9m.

The assessment has considered the current measures being put in place by the Group to preserve cash and ensure continuity of operations through:

•      Ensuring continuation of its supply chain, building on the benefit of having its own manufacturing sites and by securing alternative third-party supply lines.

•      Maintaining geographical sales diversification, focusing sales to online customers and seeking new revenue streams around the globe.

•      Ability to service both the major global retail chains and significant distribution to the independent eyewear market.

•      Rationalisation of the Group's operations and organisational structure to enhance operational efficiency and improve cost leverage

Basis of preparation

The interim consolidated financial statements for the six months ended 30 June 2026 have been prepared in accordance with IAS 34 Interim Financial Reporting and with accounting policies that are consistent with the Group's Annual Report and Financial Statements for the period ended 31 December 2025. Accounting policies are included in detail within the latest Annual Report.

The financial information for the period ended 30 June 2026 and the comparative financial information for the period ended 30 June 2025 in this interim report do not constitute statutory accounts for either period under section 434 of the Companies Act 2006 and are unaudited.

 

 

 

 

 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

3.     CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

The preparation of the Group's historical information requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts of the assets or liabilities in the future.

Estimation uncertainty

In addition to the going concern section of note 2, the key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial period, are described below.

Right of return liability

Management applies assumptions in determining the right of return liability and the associated right of return asset. These assumptions are based on analysis of historical data trends but require estimation of appropriate time periods and expected return rates. The right of return liability at the period end is £15,622,000 (31 December 2025: £15,655,000) and is calculated in line with the methodology used as at 31 December 2025.

 


 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

4.      SEGMENT INFORMATION

The Group now operates in two operating segments, which results in the following two reporting segments:

• Frames and Optics product distribution.

• Manufacturing - being OEM and manufacturing distribution.

The criteria applied to identify the operating segments are consistent with the way the Group is managed. In particular, the disclosures are consistent with the information regularly reviewed by the Executive team in their role as Chief Operating Decision Makers, to make decisions about resources to be allocated to the segments and to assess their performance. Segment asset and liability information is not provided to the Chief Operating Decision Makers.

The reportable segments subject to disclosure are consistent with the organisation model adopted by the Group during the six months ended 30 June 2026 are set out as below:


Frames and


Manufacturing


Total before


Adjustments


   Total


  Optics




adjustments &


& eliminations








eliminations






£'000


£'000


£'000


£'000


  £'000

Revenue










   External

90,462


8,687


99,149


-


99,149

   Internal

843


1,791


2,634


(2,634)


-


91,305


10,478


101,783


(2,634)


99,149

Cost of sales

(43,399)


(6,541)


(49,940)


3,066


(46,874)











Gross profit

47,906


3,937


51,843


432


52,275











Expenses

(41,139)


(3,471)


(44,610)


(1,764)


(46,374)

Operating profit/(loss)

6,767


466


7,233


(1,332)


5,901

 

Non-underlying costs









 

(2,471)

Exchange adjustment

on borrowings









(43)

Share of profit of associates









-

Finance costs









(1,668)

Finance income









37

Taxation









(1,885)

Loss for the period - continuing operations









(129)

 



 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

4.      SEGMENT INFORMATION (continued)

The reportable segments subject to disclosure are consistent with the organisation model adopted by the Group during the six months ended 30 June 2025 are set out as below:


Frames and


Manufacturing


Total before


Adjustments


   Total


  Optics




adjustments &


& eliminations








eliminations






£'000


£'000


£'000


£'000


  £'000

Revenue










   External

90,404


7,177


97,581


42


97,623

   Internal

994


692


1,686


(1,686)


-


91,398


7,869


99,267


(1,644)


97,623

Cost of sales

(44,145)


(4,727)


(48,872)


1,819


(47,053)











Gross profit

47,253


3,142


50,395


175


50,570











Expenses

(42,136)


(3,552)


(45,688)


(2,146)


(47,834)

Operating profit/(loss)

5,117


(410)


4,707


(1,971)


2,736

 

Non-underlying costs









 

(247)

Exchange adjustment

on borrowings









1,399

Share of profit of associates









6

Finance costs









(1,612)

Finance income









72

Taxation









(2,087)

Profit for the period - continuing operations









267

 

Non-underlying costs, finance costs and income, and taxation are not allocated to individual segments as the underlying instruments are managed on a Group basis. Adjusted items relate to elimination of all intra-Group items including any profit adjustments on intra-Group revenues that are eliminated on consolidation, along with the profit and loss items of the parent company.

Geographical analysis

The revenue of the Group is attributable to the one principal activity of the Group. The Group's revenue by destination is split in the following geographic areas:




 

Unaudited

6 months ended

30 June 2026


 

Unaudited

6 months ended

30 June 2025




£'000


£'000

United Kingdom



8,514


10,001

Europe (excluding UK)



48,991


46,120

North America



36,619


35,780

South America



1,025


1,113

Asia



2,973


2,045

Australia



834


2,403

Other



193


161




99,149

 

97,623

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

5.      EARNINGS PER SHARE

Basic Earnings per Share ("EPS") is calculated by dividing the profit or loss for the period attributable to ordinary equity holders of the parent by the weighted average number of ordinary shares outstanding during the period.

Diluted EPS is calculated by dividing the profit or loss attributable to ordinary equity holders of the parent by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on conversion of all the dilutive potential ordinary shares into ordinary shares, to the extent that the inclusion of such shares is not anti-dilutive. Refer to note 11 in relation to the share options outstanding as at 30 June 2026.

6 months ended 30 June 2026

Basic weighted average number of Ordinary Shares ('000)

 

Total

Earnings

 (£'000)

Earnings per share (pence)

Basic EPS

102,210


(488)

(0.48)

Diluted EPS

102,210


(488)

(0.48)

Basic EPS from continuing operations

102,210


(129)

(0.13)

Diluted EPS from continuing operations

102,210


(129)

(0.13)

Basic Underlying EPS

102,210


3,264

3.19

Diluted Underlying EPS

107,891


3,264

3.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

 

5.      EARNINGS PER SHARE (continued)

 

6 months ended 30 June 2025

Basic weighted average number of Ordinary Shares ('000)

 

Total

Earnings

 (£'000)

Earnings per share (pence)

Basic EPS

101,672


(4,612)

(4.54)

Diluted EPS

101,672


(4,612)

(4.54)

Basic EPS from continuing operations

101,672


267

0.26

Diluted EPS from continuing operations

107,058


267

0.25

Basic Underlying EPS

101,672


2,223

2.19

Diluted Underlying EPS

107,058


2,223

2.08

 

 

12 months ended 31 December 2025

Basic weighted average number of Ordinary Shares ('000)

 

Total

earnings

 (£'000)

Earnings per share (pence)

Basic EPS

101,672


(9,558)

(9.40)

Diluted EPS

101,672


(9,558)

(9.40)

Basic EPS from continuing operations

101,672


(3,290)

(3.24)

Diluted EPS from continuing operations

101,672


(3,290)

(3.24)

Basic Underlying EPS

101,672


7,400

7.28

Diluted Underlying EPS

107,749


7,400

6.87

 

Within INSPECS Group plc, each Ordinary share carries the right to participate in distributions, as respects dividends and as respects capital on winding up.



 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

6.     TRADE AND OTHER RECEIVABLES




 

Unaudited

As at

30 June 2026


 

Unaudited

As at

30 June 2025


 

As at

31 December

2025

 

 



             £'000


          £'000


             £'000

Trade receivables



24,671


24,056


27,179

Prepayments



2,902


3,347


2,877

Other receivables



5,875


5,764


7,409












33,448

 

33,167

 

37,465

 

7.    CASH AND CASH EQUIVALENTS


Unaudited


Unaudited


As at

    31 December

2025


As at


As at



30 June 2026


30 June 2025



£'000

 


£'000

 


£'000

As presented in the consolidated statement of financial position

25,961


22,667


15,986







Cash and cash equivalents of entity presented as held for sale

-


157


-







As presented in the consolidated statement of cash flows

 

25,961

 

 

22,824

 

 

15,986









 

8.    TRADE AND OTHER PAYABLES


Unaudited


Unaudited


As at

    31 December

2025


As at


As at



30 June 2026


30 June 2025



£'000

 


£'000

 


£'000

Trade payables

22,984


21,087


23,432

Social security and other taxes

3,274


3,092


3,081

Royalties

2,236


2,127


1,793

Accruals

10,288


10,617


12,216








38,782


36,923

 

40,522









 

 

 

 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

9.    NET DEBT


Unaudited


Unaudited


As at

    31 December

2025


As at


As at



30 June 2026


30 June 2025



£'000

 


£'000

 


£'000

 

Cash and cash equivalents

25,961


22,667


15,986

Interest bearing borrowings excl. leases

 

(41,459)


 

(44,213)


 

(46,739)

Invoice discounting

(3,185)


(2,012)


(1,580)

Net debt excluding leases

(18,683)

 

(23,558)

 

(32,333)







Lease liability

(10,233)


(12,414)


(11,457)

Net debt including leases

(28,916)


(35,972)

 

(43,790)

 

10.    NON-UNDERLYING COSTS

Non-underlying costs during the six months ended 30 June 2026 comprised £2,160,000 of professional fees and other transaction-related costs incurred in connection with the proposed acquisition and subsequent offer by Bidco 1125 Limited, which became unconditional on 12 March 2026. A further £310,000 was incurred in relation to restructuring completed across European-based subsidiaries.

Non-underlying costs during the six months ended 30 June 2025 relate to legal costs incurred in relation to the defence of a requisition for a general meeting (£137,000) and the amalgamation of European subsidiaries (£110,000).

11.    SHARE-BASED PAYMENTS

Certain employees of the Group are granted options over the shares in INSPECS Group. The options are granted with a fixed exercise price. Despite the Bidco 1125 Limited offer becoming unconditional on 12 March 2026, vested market-value options remained outstanding at 30 June 2026 as they continued to be exercisable until 12 September 2026, except where they had already lapsed following the relevant option holder's departure.

Share options outstanding at the end of the period have the following expiry dates and exercise prices:

Grant date

Vesting date

Expiry date

Exercise price per option (£)

Number of share options


10 December 2019

1 July 2022

12 September 2026

1.01

412,102


27 February 2020

27 February 2023

12 September 2026

1.95

1,923,110


22 December 2020

22 December 2023

12 September 2026

2.10

740,000


26 February 2021

26 February 2024

12 September 2026

3.25

641,036


21 June 2021

21 June 2024

12 September 2026

3.51

60,000


31 August 2021

31 August 2024

12 September 2026

3.70

155,000


23 December 2021

23 December 2024

12 September 2026

3.70

229,999


28 February 2022

26 February 2025

12 September 2026

3.75

641,036




 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

12.    DISCONTINUED OPERATIONS

As at 30 June 2025, Norville (20/20) Limited was classified as a disposal group held for sale and a discontinued operation. The Group subsequently engaged Deloitte to support efforts to sell the business or assist with implementing alternative outcomes should a sale not be possible. As at 31 December 2025, it had been determined that the business could not be sold as a going concern and Norville had ceased all revenue-generating activities. During the six months ended 30 June 2026, all remaining employees left the business and the sale of its inventory, property, plant and equipment was completed, with the residual activities principally comprising the collection and settlement of outstanding balances and completion of the wind-down process. Accordingly, Norville continued to be presented as a discontinued operation for the period. However, as the assets previously included within the disposal group have been sold, realised or otherwise written down, the Group no longer presents assets held for sale as at 30 June 2026.

The operating profit of the discontinued operation, along with the profit or loss arising from remeasurement of assets and liabilities classified as held for sale, is shown below:

 

 

Unaudited
6 months ended
30 June 2026

 

 

Unaudited
6 months ended
30 June 2025
       

 

            £'000  

 

£'000

 

REVENUE

-


2,405

Cost of sales

(92)


(1,622)





GROSS PROFIT

(92)


783

 




Distribution costs

-


(159)

Administrative expenses

(151)


(1,563)





OPERATING LOSS

(243)


(939)





Non-underlying costs

(115)


(56)

Finance costs

(1)


(119)





LOSS FOR THE PERIOD

(359)


(1,114)





Loss on the remeasurement of disposal group

-


(3,765)





LOSS FOR THE PERIOD - DISCONTINUED OPERATION

(359)


(4,879)

 




Loss per share for discontinued operations

Pence


Pence

Basic EPS for the period attributable to the equity holders of the parent

(0.35)


(4.80)

Diluted EPS for the period   attributable to the equity   holders of the parent

(0.35)


(4.80)

 

 

NOTES TO THE INTERIM CONSOLIDATED STATEMENTS (continued)

For the period ended 30 June 2026

 

13. PRIOR PERIOD ADJUSTMENTS

In accordance with IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors, the following items have been identified as prior period errors and corrected by restating comparative information. The restatements are consistent with those reported in the audited financial statements for the year ended 31 December 2025.

Prior period adjustment A - Right of return

Under IFRS 15, a right of return arises from a constructive obligation where Tura expects to accept returns after the reporting date in respect of sales recognised prior to that date. As at 30 June 2025 and preceding periods, the right of return provision was not measured using all relevant information that was available, or could reasonably have been obtained, at the time the financial statements were authorised for issue. In prior periods, the right of return provision recognised by Eschenbach was discounted in accordance with IAS 37, reflecting the time value of money where the effect was considered material. However, under IFRS 15, right of return provisions are accounted for as refund liabilities arising from variable consideration and should be measured at the amount of consideration expected to be refunded to customers, without discounting. As a result, the discounting applied by Eschenbach was not consistent with the measurement requirements of IFRS 15.

In accordance with IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors, the above has been identified as a prior period error and the right of return provision and associated asset recognised have therefore been restated as a prior period adjustment. In addition, the right of return provision recognised at the acquisition date of Tura has been recalculated, with a corresponding adjustment made to goodwill. Comparative information has been restated to reflect these adjustments. The impact of this error on the income statement was assessed and is not considered material and therefore the income statement to 30 June 2025 has not been restated.

Prior period adjustment B - Warranty provisions

In prior periods, amounts relating to warranty obligations were included within the right of return provision. However, warranty provisions represent separate obligations to repair or replace faulty products and should be presented separately from right of return provisions, which reflect refund liabilities arising from variable consideration under IFRS 15. Accordingly, the warranty provision has been reclassified and presented separately on the face of the balance sheet.

Prior period adjustment C - Goodwill foreign exchange

Under IAS 21, goodwill arising on the acquisition of a foreign operation should be treated as an asset of that foreign operation and translated into the Group's presentational currency at the closing rate at each reporting period. As at 30 June 2025 and preceding periods, the goodwill arising on acquisition of foreign operations had not been translated from the functional currency of the relevant foreign operations at the closing rate but instead has been translated at the exchange rate at the date of acquisition. This has been identified as a prior period error and the comparative information has been restated accordingly.

Prior period adjustment D - Killine revenue cut-off

Under IFRS 15, revenue should be recognised when control of goods transfers to the customer, rather than when goods are invoiced or dispatched. As at 30 June 2025 and preceding periods, revenue recognised within the Killine business included amounts recognised prior to the transfer of control to customers, primarily due to cut‑off errors where sales were recorded before delivery had occurred in accordance with contractual terms. This has been identified as a prior period error and the comparative information has been restated accordingly. The impact of this error on the income statement was assessed and is not considered material and therefore the income statement to 30 June 2025 has not been restated.

 

Prior period adjustment E - Killine work in progress

In prior periods, a consolidation adjustment to increase the value of inventory, which was first recorded in 2018, has been recorded each year in order to reconcile the accumulated losses position. Following a review of the consolidation entries, it was identified that this consolidation adjustment should have been reversed in an earlier period and therefore the value of inventory was overstated and the value of accumulated losses understated in previous periods. This has been identified as a prior period error and the comparative information has been restated accordingly. The impact of this error on the income statement was assessed and is not considered material and therefore the income statement to 30 June 2025 has not been restated.

A reconciliation of the restated Statement of Financial Position as at 30 June 2025 is shown below:

 

 


30 June 2025

£'000

Adjustment A

 

Adjustment B

Adjustment C

 

Adjustment D

 

Adjustment E

30 June 2025

(Restated)
£'000

Assets


 






Non-current assets








Goodwill

55,741

3,473

-

(3,442)

-

-

55,772

Intangible assets

20,504

-

-

-

-

-

20,504

Property, plant and equipment

25,310

-

-

-

-

-

25,310

Investments in associate and joint venture

70

-

-

-

-

-

70

Deferred tax assets

1,993

1,581

-

-

-

-

3,574


103,618

5,054

-

(3,442)



105,230

Current assets








Inventories

40,576

1,292

-

-

806

(706)

41,968

Trade and other receivables

34,397

-

-

-

(1,230)

-

33,167

Tax receivables

184

-

-

-

-

-

184

Cash and cash equivalents

22,667

-

-

-

-

-

22,667


97,824

1,292

-

-

(424)

(706)

97,986

Assets held for sale

2,392

-

-

-

-

-

2,392

Total assets

203,834

6,346

-

(3,442)

(424)

(706)

205,608

Equity








Shareholders' equity








Called up share capital

1,017

-

-

-

-

-

1,017

Share premium

89,508

-

-

-

-

-

89,508

Foreign currency translation reserve

(409)

161

-

(3,442)

129

6

(3,555)

Share option reserve

3,847

-

-

-

-

-

3,847

Merger reserve

5,340

-

-

-

-

-

5,340

Accumulated losses

(10,202)

(2,537)

-

-

(553)

(712)

(14,004)

Total equity

89,101

(2,376)

-

(3,442)

(424)

(706)

82,153

Liabilities








Non-current liabilities








Financial liabilities - borrowings








Interest-bearing loans and borrowings

43,902

-

-

-

-

-

43,902

Deferred tax liabilities

1,673

-

-

-

-

-

1,673


45,575

-

-

-

-

-

45,575

Current liabilities








Trade and other payables

36,923

-

-

-

-

-

36,923

Right of return liabilities

10,527

8,722

(3,222)

-

-

-

16,027

Warranty provision

-

-

3,222

-

-

-

3,222

Financial liabilities - borrowings








Interest-bearing loans and borrowings

12,725

-

-

-

-

-

12,725

Invoice discounting

2,012

-

-

-

-

-

2,012

Deferred and contingent consideration

991

-

-

-

-

-

991

Tax payable

4,237

-

-

-

-

-

4,237


67,415

8,722

-

-

-

-

76,137

Liabilities held for sale

1,743

-

-

-

-

-

1,743

Total liabilities

114,733

8,722

-

-

-

-

123,455

Total equity and liabilities

203,834

6,346

-

(3,442)

(424)

(706)

205,608

 

The impact of the above prior year adjustments on the Consolidated Statement of Cash Flows is considered not material, and these statements have therefore not been restated.

14.    POST BALANCE SHEET EVENTS

Since the end of the interim period on 30 June 2026, there have been no events that the directors consider material to the users of these interim statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings